CPDN is pleased to announce the following appointments to its Board of Directors
Effective Feb 1, 2024, Kirill Vendrov, currently Director, Established Medicines Group & Corporate Accounts at Johnson & Johnson Innovative Medicine, is appointed CPDN Board Chair responsible for leading the CPDN Board in carrying out its corporate governance and fiduciary duties. Kirill has served on the CPDN Board since 2020 and brings a wealth of knowledge and experience in pharmaceutical supply chain and commercial strategy.
Read More